18 results
Antiarrhythmic Medications - Vaughan Williams Classification - Summary Table
Class I agents - Sodium Channel Blockers⠀
Class II
Class I agents ... Blockers⠀ Class ... agents in this class ... Blockers Class ... Blockers ⠀ Class
Antiarrhythmics - Sodium Channel Blockers
Subclasses, Mechanisms, Indications, Side Effects
la - Quinidine, Procainamide
lb - Lidocaine, Mexiletine
Ic -
Antiarrhythmics - Sodium Channel ... Subclasses, Mechanisms, Indications ... Antiarrhythmics #Sodium #Channel ... #Blockers #ClassI ... #pharmacology #table
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
Antianginal Drugs DRUG CLASS ... #Antianginal #Medications ... Management #Therapy #Table
Angiotensin Receptor Blockers 
Recommended Dose Conversions 

Valsartan 
Irbesartan 
Losartan 
Olmesartan 
Telmisartan 
Candesartan 
Azilsartan 
Eprosartan 

A few
Recommended Dose Conversions ... at-a-glance dose conversion ... another drug in that class ... recalls, this drug class ... #Table #Dosing
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Each class of medications ... pharmacotherapy #table ... comparison #management #medications
Recommendations for initial management of Unstable Angina/NSTEMI

Flowchart for class I and class lla recommendations for initial
Flowchart for class ... I and class lla ... UnstableAngina #Management #Algorithm ... #Cardiology #Medication
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
has very minimal chance ... about this drug class ... different than other medications ... This drug class ... very tolerable medication
Class III Antiarrhythmics - Potassium Channel Blockers - Indications and Side Effects
Amiodarone
 • Suppression of VT
Class III Antiarrhythmics ... - Potassium Channel ... Blockers - Indications ... Antiarrhythmics #Potassium #Channel
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
exacerbations Drug Class ... Dosing: 250 mcg tablet ... have been a few changes ... the use of this medication ... #Roflumilast #Indications
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
Renal Epithelial Channels ... Nonspecific Cation Channel ... Heart Association class ... #Pharmacology #Medications ... #Table